Emergent BioSolutions | Capital De Empréstimo





Capital De Empréstimo Alterar Data
Acadia Pharmaceuticals USD 0 0 2025-03
Akebia Therapeutics USD 47.64M 579K 2025-09
ALKERMES USD 285.82M 639K 2024-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
ANI Pharmaceuticals USD 297.68M 310.67M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Coherus Biosciences USD 294.85M 2.33M 2025-03
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Exact Sciences USD 2.33B 9.34M 2025-09
Glaxosmithkline GBP 20.02B 4.72B 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lexicon Pharmaceuticals USD 56.11M 2.54M 2025-06
Lonza CHF 4.24B 602M 2024-12
Merck USD 39.97B 6B 2025-09
Moderna USD 610M 584M 2025-12
Myriad Genetics USD 119.5M 60.2M 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 376.72M 1.37M 2025-09
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Xoma USD 94.38M 7.82M 2025-09


Emergent BioSolutions Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.